Back to the complete issue
Tuesday, 12 January 2021

Healthcare mega-merger, dissected

What to expect from the health industry’s mega-merger: In a conference call with investors yesterday, Cleopatra Hospitals Group (CHG) CEO Ahmed Ezzeldin and Chairman Ahmed Badreldin broke down the healthcare provider’s planned acquisition of Alameda Healthcare Group’s Egypt assets. The merger, which was announced last month, is still pending regulatory approvals but is expected to close before the end of June. Key takeaways from the call:

The basics: The combined group is expected to hold around 15% of Greater Cairo’s commercial bed capacity, with CHG currently holding 8% and Alameda bringing 7% to the new entity. In terms of facilities, CHG has six facilities, while Alameda has three facilities up and running and a fourth that it expects to inaugurate in 1H2021.

The merger comes at a time when the private healthcare industry is ripe for investments — and consolidation. With a growing population and longer life expectancies, combined with an increased prevalence of chronic diseases, there’s “a huge market that’s growing every year,” said Ezzeldin. The vast majority of hospital beds — of which Egypt has 1.3 per 1,000 citizens — are owned by the health and defense ministries and university hospitals, while the private market that holds the rest of the country’s patient capacity is “totally fragmented.”

It also coincides with the ongoing roll-out of the government’s universal healthcare scheme, in which the combined company “expects to be a key partner,” said Badreldin. “With the combined scale, we expect to be able to expand our capacity in other governorates following the healthcare scheme,” he said.

What about the competition authority? The call ended without officials addressing a question from Enterprise about regulatory approval of the transaction. The Egyptian Competition Authority has expressed opposition to the merger.

Both CHG and Alameda are going into the merger on solid financial footing: CHG closed out 2020 with revenues north of EGP 2 bn, following record performance during the fourth quarter of the year, said Ezzeldin. The company is expected to release its full-year earnings in around six weeks or less, he noted. Alameda’s 9M2020 revenues come in at around EGP 1.49 bn, growing 4% y-o-y despite the pandemic.

…and they expect a bump from the merger: Overall, Cleopatra runs its facilities at 65-75% utilization, and Alameda has a utilization rate of around 50% across its hospitals, said Badreldin. CHG expects Alameda to “exhibit strong EBITDA and cashflow generation,” given the group has invested north of EGP 3.5 bn in capex over the last four years, said Badreldin. The merger is expected to accelerate the overall growth trajectory for CHG, which has been investing in the Egyptian market since 2015. Alameda’s hospitals already enjoy a strong reputation, but operate “at somewhat lower margins'' than CHG. “There is, in our view, room for EBITDA margin improvement for the Alameda assets to bring them to the same level” as CHG’s, whose flagship hospital runs at north of 30% EBITDA margins.

The merger will also improve service quality and employment prospects: Both CHG and Alameda are expected to benefit from clinical standardizations and the transfer of knowledge, allowing for enhanced patient safety and an improvement in the quality of outcomes, said Badreldin. The combination of the two healthcare players will also benefit the healthcare industry at large by creating at least 2,000 new jobs, Ezzeldin said.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.